This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Frank Zhang
Head of Market Access at uniQure


Frank Zhang is currently Head of Market Access for uniQure preparing for commercialization of first gene therapy in Hemophilia B and Huntingdon’s Disease. Prior to this position, he was with Alnylam from 2017-2019 as VP, Global and US Market Access, and launched the first RNAi product called Onpattro. He was with Celgene from 2010-2017 as Head of Market Access for Immunology and Inflammation Franchise, and launched Otezla successfully in over 25 countries. He was leading HEOR, pricing and market access for Virology franchise for J&J from 2005-2010, and was with Eli Lilly and GSK in his earlier career. Frank was a physician by training and had a Master of Public Health from Yale.

Agenda Sessions

  • PANEL: Reimbursement Models for Novel Therapies


Speakers at this event